Interpharm Holdings Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003
Period Ending	Dec '07 Dec 31, 2007	Jun '07 Jun 30, 2007	Jun '06 Jun 30, 2006	Jun '05 Jun 30, 2005	Jun '04 Jun 30, 2004	Jun '03 Jun 30, 2003
Revenue	69.21	75.59	63.36	39.91	41.1	27.52
Revenue Growth (YoY)	-5.06%	19.31%	58.74%	-2.89%	49.33%	13.20%
Cost of Revenue	57.21	53.92	45.93	30.84	31.38	22.54
Gross Profit	12	21.67	17.43	9.07	9.72	4.99
Selling, General & Admin	14.75	13.44	11.52	5.16	4.12	2.52
Research & Development	17.03	18.96	10.67	4	0.54	0.45
Operating Expenses	31.78	32.41	22.2	9.17	4.66	2.97
Operating Income	-19.78	-10.74	-4.77	-0.1	5.06	2.01
Interest Expense	-2.48	-1.28	-0.72	-0.14	-0.02	-0.28
Interest & Investment Income	-	-	-	-	0.07	0.01
EBT Excluding Unusual Items	-22.14	-12.01	-5.49	-0.23	5.11	1.74
Gain (Loss) on Sale of Investments	-	-	-	0.01	-	-
Gain (Loss) on Sale of Assets	-0.1	-0.1	-0.01	-	-	-
Asset Writedown	-0.1	-0.1	-	-	-	-
Other Unusual Items	-	-1.66	-	-	-	-
Pretax Income	-22.27	-13.87	-5.49	-0.22	5.11	1.74
Income Tax Expense	7.09	0.19	-1.7	-0.07	1.99	0.58
Net Income	-29.36	-14.06	-3.79	-0.15	3.12	1.16
Preferred Dividends & Other Adjustments	4.34	2.75	1.73	0.17	0.36	0.15
Net Income to Common	-33.69	-16.8	-5.52	-0.32	2.76	1.01
Net Income Growth	-	-	-	-	168.47%	10.74%
Shares Outstanding (Basic)	66	65	37	26	18	7
Shares Outstanding (Diluted)	66	65	37	26	69	39
Shares Change (YoY)	25.21%	78.64%	42.19%	-62.58%	76.90%	7.97%
EPS (Basic)	-0.51	-0.26	-0.15	-0.01	0.16	0.15
EPS (Diluted)	-0.51	-0.26	-0.15	-0.01	0.04	0.03
EPS Growth	-	-	-	-	34.94%	1.41%
Free Cash Flow	-29.61	-22.11	-6.03	-10.47	-2.3	-0.27
Free Cash Flow Per Share	-0.45	-0.34	-0.17	-0.41	-0.03	-0.01
Gross Margin	17.34%	28.67%	27.51%	22.73%	23.66%	18.12%
Operating Margin	-28.58%	-14.21%	-7.52%	-0.24%	12.31%	7.31%
Profit Margin	-48.68%	-22.23%	-8.71%	-0.79%	6.72%	3.69%
Free Cash Flow Margin	-42.78%	-29.25%	-9.52%	-26.22%	-5.59%	-0.98%
EBITDA	-16.57	-8.32	-3.23	1.15	5.95	2.6
EBITDA Margin	-23.94%	-11.00%	-5.10%	2.89%	14.47%	9.46%
D&A For EBITDA	3.21	2.42	1.53	1.25	0.89	0.59
EBIT	-19.78	-10.74	-4.77	-0.1	5.06	2.01
EBIT Margin	-28.58%	-14.21%	-7.52%	-0.24%	12.31%	7.31%
Effective Tax Rate	-	-	-	-	38.87%	33.29%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.